← Open Payments lookup

NICHOLAS TALABISKA: Open Payments

NPI 1881264430 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$538 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $186 · 2025 $538

Food & beverage: $538
CompanyPaymentsAmount
Gilead Sciences, Inc.2$259
ABBVIE INC.1$119
Ardelyx, Inc.3$83
GENZYME CORPORATION1$22
Novo Nordisk Inc1$20
Madrigal Pharmaceuticals1$18
Janssen Biotech, Inc.1$17

Products named: Livdelzi, LINZESS, IBSRELA, DUPIXENT, Wegovy, REZDIFFRA, TREMFYA.

Industry payments across PA — which companies pay providers there.